As described earlier, our studies using primary mouse lung cancer models have demonstrated a protective nature of TLR4 that resulted in reduced tumor numbers, specific macrophage populations, myeloid-derived suppressor cells (MDSCs), and neutrophils, among other inflammatory cell types [28–33]. The gene discussed is TLR4; the disease is neoplasm.